ALK-inhibitors as a novel potential therapy for proteasome inhibitor-resistant multiple myeloma

被引：0
作者：
Besse, Lenka
Besse, Andrej
Kraus, Marianne
Jasik, Matej
Slaby, Ondrej
Driessen, Christoph
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2851
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2851
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Proteasome inhibitors for multiple myeloma
    Okazuka, Kiyoshi
    Ishida, Tadao
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (09) : 785 - 792
  • [22] Targeting Glycolysis in Multiple Myeloma: Novel Strategies in the Treatment of Proteasome Inhibitor Resistant in Hypoxic Conditions
    Okabe, Seiichi
    Tanaka, Yuko
    Moriyama, Mitsuru
    Gotoh, Akihiko
    [J]. BLOOD, 2019, 134
  • [23] Preclinical evaluation of tropolone and proteasome inhibitor therapy for multiple myeloma
    Holstein, Sarah
    Haney, Staci
    Varney, Michelle
    Smith, Lynette
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10) : E130 - E131
  • [24] Acquisition of a multidrug-resistant phenotype with a proteasome inhibitor in multiple myeloma
    Gutman, D.
    Morales, A. A.
    Boise, L. H.
    [J]. LEUKEMIA, 2009, 23 (11) : 2181 - 2183
  • [25] Acquisition of a multidrug-resistant phenotype with a proteasome inhibitor in multiple myeloma
    D Gutman
    A A Morales
    L H Boise
    [J]. Leukemia, 2009, 23 : 2181 - 2183
  • [26] Strategies To Identify Effective Treatments For Proteasome Inhibitor Resistant Multiple Myeloma
    Van Ness, Brian
    Stessman, Holly A. F.
    Baughn, Linda B.
    Mansoor, Aatif
    Mitra, Amit
    Dolloff, Nathan G.
    Myers, Chad L.
    Zhan, Fenghuang
    Harding, Taylor
    [J]. BLOOD, 2013, 122 (21)
  • [27] Updates to the drug-resistant mechanism of proteasome inhibitors in multiple myeloma
    Bai, Yang
    Su, Xing
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (01) : 29 - 35
  • [28] Novel mechanism of drug resistance to proteasome inhibitors in multiple myeloma
    Zhou, Jianbiao
    Chng, Wee-Joo
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2019, 10 (09): : 303 - 306
  • [29] RONEPARSTAT, A NOVEL HEPARANASE INHIBITOR AS A POTENTIAL TOOL FOR MULTIPLE MYELOMA THERAPY
    Rambaldi, A.
    Barbieri, P.
    Galli, M.
    Leiba, M.
    Naggi, A.
    Sanderson, R.
    Nagler, A.
    Vlodavsky, I.
    [J]. HAEMATOLOGICA, 2014, 99 : 635 - 635
  • [30] Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma
    Staci L. Haney
    Michelle L. Varney
    Jacob T. Williams
    Lynette M. Smith
    Geoffrey Talmon
    Sarah A. Holstein
    [J]. Experimental Hematology & Oncology, 11
12345